{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:50:31Z","timestamp":1793875831892,"version":"4.7.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 123749"],"award-info":[{"award-number":["R01 123749"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CEECIND\/04663\/2017"],"award-info":[{"award-number":["CEECIND\/04663\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cgh.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T02:51:53Z","timestamp":1729824713000},"page":"1612-1622.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anti-integrin \u03b1v\u03b26 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity"],"prefix":"10.1016","volume":"23","author":[{"given":"Hannah","family":"Bloemen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-3400","authenticated-orcid":false,"given":"Alexandra E.","family":"Livanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrielly","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catarina","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno R.","family":"Bourgonje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tankelevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Herb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Anast\u00e1cio","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia M.P.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Petralia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Frederic","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Mehandru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.10.005_bib1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","article-title":"Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies","volume":"20","author":"Trivedi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.10.005_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040420","article-title":"Relationship of inflammatory bowel disease and primary sclerosing cholangitis","volume":"11","author":"Fausa","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2024.10.005_bib3","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.10.005_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.10.005_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/apt.14393","article-title":"Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients","volume":"47","author":"Nordenvall","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.10.005_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/cbin.10258","article-title":"Alphavbeta6 is required in maintaining the intestinal epithelial barrier function","volume":"38","author":"Yu","year":"2014","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.cgh.2024.10.005_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s10495-023-01921-6","article-title":"Exploring the role of ITGB6: fibrosis, cancer, and other diseases","volume":"29","author":"Zhang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.cgh.2024.10.005_bib8","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1053\/j.gastro.2021.02.019","article-title":"Identification of an anti-integrin \u03b1v\u03b26 autoantibody in patients with ulcerative colitis","volume":"160","author":"Kuwada","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.10.005_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.gastro.2022.12.042","article-title":"Anti-integrin \u03b1v\u03b26 autoantibodies are a novel biomarker that antedate ulcerative colitis","volume":"164","author":"Livanos","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.10.005_bib10","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.21849","article-title":"Role of alphavbeta6 integrin in acute biliary fibrosis","volume":"46","author":"Wang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.10.005_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2008.04.009","article-title":"Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression","volume":"135","author":"Patsenker","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.10.005_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.28274","article-title":"Integrin \u03b1v\u03b26 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis","volume":"63","author":"Peng","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.10.005_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.10.005_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.10.005_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00042737-199704000-00007","article-title":"Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group","volume":"9","author":"Lennard-Jones","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.10.005_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG Clinical Guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.10.005_bib17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.10.005_bib18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s00535-023-02006-6","article-title":"Anti-integrin \u03b1v\u03b26 autoantibodies in patients with primary sclerosing cholangitis","volume":"58","author":"Yoshida","year":"2023","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.10.005_bib19","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.10.005_bib20","article-title":"Fluctuating biomarkers in primary sclerosing cholangitis: a longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF","volume":"3","author":"Fossdal","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2024.10.005_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000366","article-title":"African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis","volume":"8","author":"Yazdanfar","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2024.10.005_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","article-title":"The integrin \u03b1v\u03b26 binds and activates latent TGF\u03b21: a mechanism for regulating pulmonary inflammation and fibrosis","volume":"96","author":"Munger","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.cgh.2024.10.005_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cgh.2024.10.005_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ecco-jcc\/jjab157","article-title":"The effect of phenotype and genotype on the plasma proteome in patients with inflammatory bowel disease","volume":"16","author":"Bourgonje","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.10.005_bib26","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.immuni.2012.08.026","article-title":"Ly6Chi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells","volume":"37","author":"Zigmond","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cgh.2024.10.005_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ibd.20019","article-title":"Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease","volume":"13","author":"Rojo","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.10.005_bib28","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1074\/jbc.M805289200","article-title":"CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2-and CCL20-mediated restitution of colonic epithelial cells","volume":"284","author":"Vongsa","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cgh.2024.10.005_bib29","doi-asserted-by":"crossref","first-page":"9165","DOI":"10.3390\/ijms21239165","article-title":"Role of pd-l1 in gut mucosa tolerance and chronic inflammation","volume":"21","author":"Chulkina","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cgh.2024.10.005_bib30","article-title":"Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese","volume":"4","author":"Jia","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.cgh.2024.10.005_bib31","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1136\/gutjnl-2018-317872","article-title":"Glial cell line-derived neurotrophic factor (GDNF) mediates hepatic stellate cell activation via ALK5\/Smad signalling","volume":"68","author":"Tao","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.10.005_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/HEP.0000000000000287","article-title":"Regulatory role and translational potential of CCL11 in liver fibrosis","volume":"78","author":"Kong","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.10.005_bib33","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/liv.13092","article-title":"Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis","volume":"36","author":"Zweers","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.10.005_bib34","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hep.30237","article-title":"Simtuzumab for primary sclerosing cholangitis: phase 2 study results with insights on the natural history of the disease","volume":"69","author":"Muir","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.10.005_bib35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4254\/wjh.v6.i4.178","article-title":"Update on inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"6","author":"Tsaitas","year":"2014","journal-title":"World J Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524009698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524009698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:13:53Z","timestamp":1762550033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524009698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1542356524009698"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.10.005","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-integrin \u03b1v\u03b26 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the AGA Institute","name":"copyright","label":"Copyright"}]}}